Search Within

Nadeem Riaz

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (16)
  3. Research Letter (2)
Groups
  1. GSK Faculty (49)
  2. Human Oncology and Pathogenesis Program (49)
  3. Radiation Oncology, Department of (49)
  4. Department of Medicine (45)
  5. Solid Tumor Oncology Division (45)
  6. Department of Pathology and Laboratory Medicine (38)

More Groups

People
  1. Timothy Chan (19)
  2. Jorge Reis-Filho (15)
  3. Vladimir Makarov (14)
  4. Michael Berger (13)
  5. Luc Morris (12)
  6. Abraham Hakimi (11)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (7)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Clinical Cancer Research (6)
  3. Annals of Oncology (4)
  4. Cancer Research (4)
  5. Nature Genetics (3)
  6. Thyroid (3)

More Publications

Publishers
  1. American Association for Cancer Research (12)
  2. Nature Publishing Group (10)
  3. American Society of Clinical Oncology (8)
  4. Oxford University Press (4)
  5. Mary Ann Liebert, Inc (3)
  6. Elsevier Inc. (2)

More Publishers

Results (49)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: Data from a randomized phase III trial
    Journal Article

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Sanchez, A.; Liu, M.; Nixon, B. G.; Vuong, L.; Ostrovnaya, I.; Chen, Y. B.; Reuter, V.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • ERCC2 helicase domain mutations confer nucleotide excision repair deficiency and drive cisplatin sensitivity in muscle-invasive bladder cancer
    Journal Article

    Li, Q.; Damish, A. W.; Frazier, Z.; Liu, D.; Reznichenko, E.; Kamburov, A.; Bell, A.; Zhao, H.; Jordan, E. J.; Gao, S. P.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driver
    Meeting Abstract

    Dong, Y.; Ganly, I.; Makarov, V.; Kuo, F.; Deraje, S.; Reznik, E.; Seshan, V.; Nanjangud, G.; Morris, L.; Riaz, N.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy with or without concurrent chemotherapy in nonanaplastic thyroid cancer with unresectable or gross residual disease
    Journal Article

    Beckham, T. H.; Romesser, P. B.; Groen, A. H.; Sabol, C.; Shaha, A. R.; Sabra, M.; Brinkman, T.; Spielsinger, D.; McBride, S.; Tsai, C. J.; more...
    Thyroid (2018)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes
    Journal Article

    Ganly, I.; Makarov, V.; Deraje, S.; Dong, Y.; Reznik, E.; Seshan, V.; Nanjangud, G.; Eng, S.; Bose, P.; Kuo, F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
    Journal Article

    Chowell, D.; Morris, L. G. T.; Grigg, C. M.; Weber, J. K.; Samstein, R. M.; Makarov, V.; Kuo, F.; Kendall, S. M.; Requena, D.; Riaz, N.; more...
    Science (2018)

    Fulltext@MSK | Save
  • Integrated biomarker analysis for 412 renal cell cancer (RCC) patients (pts) treated on the phase 3 COMPARZ trial: Correlating common mutation events in PBRM1 and BAP1 with angiogenesis expression signatures and outcomes on tyrosine kinase inhibitor (TKI) therapy
    Meeting Abstract

    Voss, M. H.; Kuo, F.; Chen, D.; Marker, M.; Patel, P.; Redzematovic, A.; Riaz, N.; Chan, T. A.; Choueiri, T. K.; Hsieh, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save